Thymosin beta 10 Antikörper (AA 38-43)
Kurzübersicht für Thymosin beta 10 Antikörper (AA 38-43) (ABIN109910)
Target
Alle Thymosin beta 10 (TMSB10) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- AA 38-43
- 
                                            Spezifität
- Human Thymosin 6153810 (aa 38-43) Crossreactivity with human Thymosin 6153810 There were no cross reactivities obtained with human Thymosin 615384, Thymosin 615389, Thymosin 6153815, Thymosin 615384 (aa 1-4) peptide, and Thymosin 615384 (aa 1-14)
- 
                                            Immunogen
- Synthetic human Thymosin 6153810 (aa 38-43) KLH-conjugated (krseis)
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- ELISA (1/4.000) This antibody has not been tested for use in all applications. This does not necessarily exclude its use for non-tested procedures. The stated dilutions are recommendations only. We suggest that the applicant titrates the antibody in his/her system using appropriate negative/positive controls.
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Lyophilized
- 
                                            Rekonstitution
- Resuspend in aqua bidest.
- 
                                            Lagerung
- 4 °C
 
- 
                                            
- 
    - Thymosin beta 10 (TMSB10)
- 
                                            Andere Bezeichnung
- Thymosin Beta10
- 
                                            Hintergrund
- Serum
- 
                                            Gen-ID
- 9168
- 
                                            Pathways
- Regulation of Actin Filament Polymerization, Maintenance of Protein Location
 Target
- 
                    
 
                                     
                                     
                                    